JPRN-UMIN000032515
Recruiting
未知
HEMLIBRA Subcutaneous injection General Drug Use Surveillance(in Hemophilia A with Inhibitors). - HEMLIBRA General Drug Use Surveillance(in Hemophilia A).
ConditionsHemophilia A
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hemophilia A
- Sponsor
- Chugai Pharmaceutical Co. Ltd.
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •No criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
HEMLIBRA Subcutaneous Injection, General drug use-results survey - Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with acquired hemophilia ARoutine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with acquired hemophilia AJPRN-UMIN000048156Chugai Pharmaceutical Co. Ltd.150
Completed
Not Applicable
HEMLIBRA Subcutaneous injection Special Drug Use Surveillance (with Hemophilia A without Inhibitors).JPRN-UMIN000037503Chugai Pharmaceutical Co. Ltd.87
Recruiting
Not Applicable
EPKINLY Subcutaneous Injection General use-results surveillance (All case): OBSC3013-39D-ERelapsed or refractory large B-cell lymphoma and relapsed or refractory follicular lymphomaJPRN-jRCT2031230525Genmab K.K. Drug safety and pharmacovigilance250
Completed
Not Applicable
The therapeutic effect of intradermal injection of Measles, Mumps, and Rubella vaccine in treatment of palmoplantar warts in patients unresponsive to treatmentIRCT2016101027636N3Vice chancellor for Research of Mazandaran University of Medical Sciences60
Recruiting
Phase 2
effects of rituximab in patients with pemphigus vulgaris with oral lesionsIRCT20240604062002N1Tabriz University of Medical Sciences20